Unity Biotechnology, Inc. - stock earnings
UBX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -15.3 million USD | ? USD |
2023Q2 | -12.2 million USD | ? USD |
2023Q1 | -12.1 million USD | ? USD |
2022Q4 | -13.8 million USD | -236000 USD |
2022Q3 | -14.3 million USD | ? USD |
2022Q2 | -14.0 million USD | 236000 USD |
2022Q1 | -19.6 million USD | ? USD |
2021Q4 | -10.7 million USD | 4.8 million USD |
2021Q3 | -16.5 million USD | ? USD |
2021Q2 | -17.8 million USD | ? USD |
2021Q1 | -15.8 million USD | ? USD |
2020Q4 | -19.6 million USD | ? USD |
2020Q3 | -27.6 million USD | ? USD |
2020Q2 | -18.7 million USD | ? USD |
2020Q1 | -28.0 million USD | ? USD |
2019Q4 | -18.0 million USD | ? USD |
2019Q3 | -21.7 million USD | ? USD |
2019Q2 | -23.7 million USD | ? USD |
2019Q1 | -18.8 million USD | ? USD |
2018Q4 | -21.9 million USD | ? USD |
2018Q3 | -18.3 million USD | ? USD |
2018Q2 | -20.0 million USD | ? USD |
2018Q1 | -16.1 million USD | ? USD |
2017Q4 | -12.5 million USD | 1.4 million USD |
2017Q3 | -11.8 million USD | ? USD |
2017Q2 | -11.4 million USD | ? USD |
2017Q1 | -8.9 million USD | ? USD |
2016Q4 | -30.4 million USD | ? USD |
UBX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -52.5 million USD | ? USD |
2022 | -57.7 million USD | 236000 USD |
2021 | -60.0 million USD | 4.8 million USD |
2020 | -91.9 million USD | ? USD |
2019 | -74.9 million USD | ? USD |
2018 | -76.4 million USD | ? USD |
2017 | -44.7 million USD | 1.4 million USD |
2016 | -30.4 million USD | ? USD |
UBX
Price: $1.60
52 week price:
Earnings Per Share: -3.20 USD
P/E Ratio: -0.53
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 71934
Market Capitalization: 25.5 million